Clinical Trial Update: Arsenic Trioxide in Treating Patients With Stage IVB or Recurrent Cervical Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating arsenic trioxide in patients with stage IVB or recurrent cervical cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Cervical Cancer | Phase 2 | Status: COMPLETED